Oxford Biomedica Solutions
Briana Burdick is currently serving as a Quality Operations Specialist at Revvity since October 2023. Prior to this role, Briana worked as a QC Analyst II: Molecular at Oxford Biomedica Solutions and as a Quality Control Analyst at 2seventy bio, where responsibilities included performing qPCR, DNA extraction, and cell culturing, as well as peer reviewing assays and ensuring GDP compliance. Experience also includes working at Moderna as a MA II in Clinical DNA Plasmid Operations, focusing on DNA sequencing and assay updates for vaccine development. Beginning a career at Quanterix as a Manufacturing Associate, Briana conducted biomarker analysis through ELISA methods for early detection of antibodies. Educational qualifications consist of a Bachelor's degree in Biology, with a minor in Math and Chemistry from Salem State University, following studies at the University of Massachusetts Lowell.
Oxford Biomedica Solutions
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.